...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith-Oncology Pipeline
6
Mar 16, 2021 08:18AM
9
Mar 18, 2021 03:12PM
6
Mar 18, 2021 04:01PM
3
Mar 18, 2021 05:10PM

,,hummmm,,great posts by all,,,,,I am not sure present shareholders would bail if we went to the nasdaq,,,,,I dont think I would until at least trial data tells me to!!,,,,....what I see moving up to a respected exchange is,,,,,, large investor base,,,, access to the company by US funds and beyond.....visibility,,,,,,,liquidity,,,etc,,the only issue would be the size of the ball gag we would need for DMcC,,,!!!!,,,,,most of us will have our estate in probate before this team might actually build shareholder value at any rate,,,and value might still be only be met by accident!!!,,at least we have some sort of business plan going in Zenith,,unlike RVX,,but most likely only because professionals BPs are involved!! No nonsense aspirations out of our partners!!,,They are interested in hard fact rest assured!

2
Mar 19, 2021 06:49AM
4
Mar 19, 2021 11:19AM
5
Mar 19, 2021 11:23AM
6
Mar 19, 2021 11:57AM
2
Mar 22, 2021 04:08PM
3
Mar 22, 2021 05:34PM
2
Mar 23, 2021 05:33AM
5
Mar 23, 2021 07:54AM
4
Mar 23, 2021 09:16AM
8
Mar 23, 2021 01:45PM
4
Mar 23, 2021 02:24PM
2
Mar 23, 2021 03:27PM
2
Mar 23, 2021 04:33PM
Share
New Message
Please login to post a reply